11 Leukemia Clinical Trials in Madison, WI (2026)

Q: How do I join a clinical trial in Madison?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you.

Recruiting Leukemia Studies in Madison

NCT05810064Recruiting

Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)

The purpose of this retrospective cohort study is to evaluate the effectiveness of an EHR-based clinical decision support system (CDS) for automatically screening older adult ED patients for risk of f...

Madison, WI30,000 participantsUniversity of Wisconsin, Madison

View Study Details

NCT06771830Recruiting

Evaluation of Pediatric eCART Implementation

This is a study comparing 3 years of retrospective data (pre-implementation) to 2 years of prospective data after the implementation of a pediatric version of Electronic Cardiac Arrest Risk Triage (pe...

Madison, WINA30,000 participantsUniversity of Wisconsin, Madison

View Study Details

NCT05947851Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

The purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study hypothese...

Madison, WIPHASE3735 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07132918Recruiting

HEARTS Trial for Thoracic Cancers

The goal of this clinical trial is to compare a new way of using magnetic resonance-guided adaptive radiation therapy (MRgART) to the standard of care linear accelerator (LINAC) radiation treatment in...

Madison, WIPHASE260 participantsUniversity of Wisconsin, Madison

View Study Details

NCT04919382Recruiting

Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung cancer that has spread to other places in the body (metasta...

Madison, WIPHASE256 participantsDwight Owen

View Study Details

NCT05068232Recruiting

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

This this study is for individuals who have treatment-naïve extensive-stage small cell lung cancer (small cell lung cancer that wont respond to treatment). Doctors leading this study hope to learn if ...

Madison, WIPHASE249 participantsUniversity of Chicago

View Study Details

NCT05101551Recruiting

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

This is a Phase 1, open label, multicenter, dose finding study with dose expansion intended to evaluate the safety and tolerability of talazoparib in combination with conventional chemotherapy. Prelim...

Madison, WIPHASE134 participantsNorman J. Lacayo

View Study Details

NCT06222580Recruiting

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

This phase I trial tests the safety, side effects, and best dose of SNDX-5613 and gilteritinib for treating patients with acute myeloid leukemia that has come back after a period of improvement (relap...

Madison, WIPHASE130 participantsUma Borate

View Study Details

NCT02508038Recruiting

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

This phase I trial studies the safety of transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with the immunomodulating ...

Madison, WIPHASE122 participantsUniversity of Wisconsin, Madison

View Study Details

NCT05642455Recruiting

SPEARHEAD-3 Pediatric Study

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....

Madison, WIPHASE120 participantsAdaptimmune

View Study Details

NCT04785989Recruiting

In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)

Metabolic reprogramming has been identified as a hallmark of cancer. Almost a century after Otto Warburg initially discovered increased glycolytic activity in tumor tissue ("Warburg effect"), therapeu...

Madison, WI16 participantsUniversity of Wisconsin, Madison

View Study Details

About Leukemia Clinical Trials in Madison

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 11 leukemia clinical trials recruiting participants in Madison, WI. These studies are seeking a combined 61,022 participants. Research is being sponsored by University of Wisconsin, Madison, Merck Sharp & Dohme LLC, Dwight Owen and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Madison — FAQ

Are there leukemia clinical trials in Madison?

Yes, there are 11 leukemia clinical trials currently recruiting in Madison, WI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Madison?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you about next steps.

Are clinical trials in Madison free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Madison studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 11 active trials in Madison are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 17, 2026 from ClinicalTrials.gov